New York State Common Retirement Fund Opti Nose, Inc. Transaction History

New York State Common Retirement Fund

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	SELL	$0.82 - $1.44 $38,559 - $67,714	-47,024 Reduced 98.71%	615 $1,000
Q1 2024 May 07, 2024	SELL	$1.17 - $1.94 $225 - $374	-193 Reduced 0.4%	47,639 $70,000
Q3 2023 Nov 07, 2023	SELL	$0.93 - $1.38 $31,218 - $46,323	-33,568 Reduced 41.24%	47,832 $59,000
Q2 2023 Aug 07, 2023	BUY	$1.11 - $2.05 $90,354 - $166,870	81,400 New	81,400 $100,000
Q3 2021 Nov 02, 2021	SELL	$2.35 - $3.16 $735 - $989	-313 Closed	0 $0
Q2 2021 Aug 02, 2021	SELL	$2.91 - $3.83 $51,178 - $67,358	-17,587 Reduced 98.25%	313 $1,000
Q4 2018 Feb 08, 2019	SELL	$5.84 - $11.92 $113,179 - $231,009	-19,380 Reduced 51.98%	17,900 $111,000
Q2 2018 Aug 10, 2018	BUY	$18.75 - $28.46 $599,625 - $910,150	31,980 Added 603.4%	37,280 $1.04 Million
Q4 2017 Feb 13, 2018	BUY	$15.2 - $20.76 $80,560 - $110,028	5,300	5,300 $100,000

88.3M

Ticker OPTN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 83,277,504
Market Cap $42.5M
Description
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.